Similarly, TBX2 expression was significantly up-regulated in platinum-resistant ovarian cancer patients, cisplatin-resistant endometrial cancer patients and in poor responders to postoperative adjuvant chemotherapy in stage II/III gastric cancer [18,46,54]. The gene discussed is TBX2; the disease is gastric cancer.